The World Health Organization (WHO) has highlighted the importance of healthcare innovation, a central element of increasing the productivity, efficiency, reliability, sustainability and security of the healthcare future that affects the citizens of every country.
The relationship between health and other sectors, such as the economic and quality-of-life sectors, is increasingly close. The post-emergency health care period we are going through makes this clear to us every day. In order to have a good standard of living, it is necessary to start with safeguarding health. This inevitably translates into investment in research, equitable conditions of access to care, and acceleration of processes related to health services.
Every citizen, being a patient or potential patient, should be able to benefit from a smooth, valuable health care experience, in which the efficiency of the system is demonstrated through accurate management of issues, preventive monitoring, access to early care, and all the conditions that promote a better lifestyle. How to translate this, in economic terms? Is it possible to be part of an efficient health care system without an uncontrolled increase in health care costs?
Medical innovation at the heart of the technological revolution
CB Insights, through its “State of HealthCare” report, highlights some numbers that speak volumes:
In the second quarter of 2021, of the $35 billion invested in Equity, as much as $8.2 billion was invested in Medical Device companies. The importance of this figure increases when we consider that, in the first quarter of that year, of the $32 billion invested, only $4.8 was allocated to Medical Device
In Europe, investments doubled, quarter after quarter, to $6.9 billion, with a clear focus – exceeding 50 percent – on “early stage” investments, i.e., early innovative stages
The most significant investments involve: artificial intelligence, telemedicine, medical devices, applied technologies for mental health management, and digital therapeutics
Healthcare innovation in Italy: present and future
At this moment in history, what is crucial for Italy is to adopt a European vision, focusing on collaboration among existing businesses in order to compete globally.
Let us not forget that everyone’s relationship with health management in recent years has transformed and will continue to do so, faster and faster. Therefore, the health care system must know how to evolve, both with respect to value proposition and approach toward performance, products, and services.
In such a dynamic context, the level of innovation is very high and is in fact one of the most active-and important-in Italy.
Connecting to all these health and economic dynamics, the Numantec Group wants to accelerate innovation in medical devices and position itself as a benchmark in the global market with varied yet focused know-how. Indeed, the companies that are part of the group specialize in unique healthcare solutions and are constantly engaged in research and implementation of cutting-edge devices.
The application of innovative medical devices
The added value of healthcare innovation is tangible in every area: it enables optimization of performance, contributing to reduced healthcare costs; it improves patient care, before, after and during treatment and care; and it improves the professional performance of medical staff, in terms of both operations and outcomes.
Health care innovation thus becomes a key part of the medical world because it enables health care problems to be addressed on a larger scale, with targeted focus. New and exciting value opportunities open up to healthcare organizations implementing innovative technologies, including the inevitable attractiveness to patients and staff dictated by ever-increasing efficiency.
